[
    [
        {
            "time": "",
            "original_text": "华大基因：截至目前，上市公司属于高新技术企业，享受15%的企业所得税税率优惠政策",
            "features": {
                "keywords": [
                    "华大基因",
                    "高新技术企业",
                    "所得税优惠",
                    "政策"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华大基因：截至目前，上市公司属于高新技术企业，享受15%的企业所得税税率优惠政策",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华大基因(300676.SZ)子公司十三项产品取得医疗器械注册证",
            "features": {
                "keywords": [
                    "华大基因",
                    "子公司",
                    "医疗器械",
                    "注册证"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗设备",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华大基因(300676.SZ)子公司十三项产品取得医疗器械注册证",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "华大基因：截至2020年末，公司新冠检测产品已覆盖全球超过180个国家和地区，海外累计运营‘火眼’实验室超过80个",
            "features": {
                "keywords": [
                    "华大基因",
                    "新冠检测",
                    "火眼实验室",
                    "全球化布局"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "全球市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：截至2020年末，公司新冠检测产品已覆盖全球超过180个国家和地区，海外累计运营‘火眼’实验室超过80个",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "华大基因：截至2020年底，公司研发投入金额为6.36亿元，同比增长90.33%，研发人员为723人，占总人数的比例达19.14%",
            "features": {
                "keywords": [
                    "华大基因",
                    "研发投入",
                    "研发人员",
                    "同比增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "研发驱动",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华大基因：截至2020年底，公司研发投入金额为6.36亿元，同比增长90.33%，研发人员为723人，占总人数的比例达19.14%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]